- Home
- Aesthetic gynaecology
- Vaginal rejuvenation
- Vaginal laser
Vaginal laser: indications, results and risks
Vaginal laser has been studied mainly in genitourinary syndrome of menopause, with mixed results. See how it works, for whom it makes sense, how it is carried out and what risks exist.
Quando existir, entra aqui e também no cartão da página do blog.
In this article
Vaginal laser is the most widely promoted technique within so-called “vaginal rejuvenation”. It is presented as a quick fix, without surgery and without hormones, for dryness, pain during sex, urine leakage and laxity. The reality is more nuanced: laser has been studied mainly in genitourinary syndrome of menopause, the results are mixed and long-term data are still lacking.
In this article we explain how it works, for whom it may make sense, how the treatment is carried out, what results to expect and what risks exist.
Three ideas to remember.
Fica por baixo do resumo, se existir uma segunda foto.
How it works
Laser emits concentrated light that is absorbed by the water in the tissues and converted into heat. In fractional lasers, this energy is distributed in tiny dots, leaving intact tissue between them. The idea is to cause controlled microinjuries that stimulate regeneration: more collagen, more blood vessels and a thicker vaginal epithelium. Studies with biopsies have shown these changes in some women (Zerbinati et al., 2015), but changes in the tissues do not always translate into an improvement in symptoms.
The two main types
- Fractional CO2 laser. Acts by vaporising tiny columns of tissue. It is the most studied in genitourinary syndrome of menopause.
- Er:YAG (erbium) laser. Acts mainly by heating, with less vaporisation. Some versions were developed for urine leakage and laxity.
Each manufacturer has its own protocols and parameters, which makes it difficult to compare studies. It has not been shown that one type is superior to the other.
What it was studied for
- Genitourinary syndrome of menopause (dryness, burning, pain during sex): the indication with the most studies.
- Urine leakage on effort: studies with mixed results, covered in the article on vaginal laser for urine leakage.
- Vaginal laxity: few studies, with a significant placebo effect.
- Vulval lichen sclerosus: studies are preliminary; it does not replace topical corticosteroids, which remain the standard treatment.
Who it may make sense for
Vaginal laser is most often considered for women with genitourinary syndrome of menopause who cannot or do not wish to use vaginal oestrogen, such as some women with a history of breast cancer who are receiving endocrine therapy. Even then, guidelines recommend trying moisturisers and lubricants first, discussing local hormonal options with the oncologist and only then considering laser, with a clear understanding that the evidence is limited.
It is not indicated as a first-line treatment for women who can use vaginal oestrogen, or for symptoms that have not been assessed.
What the treatment is like
- Prior assessment:clinical history, gynaecological examination, exclusion of infection and an up-to-date smear test or HPV test.
- Session:the woman lies in the same position as for a gynaecological examination. A probe is inserted into the vagina and rotated while the laser is applied. The vulva may also be treated. The procedure takes around 10 to 20 minutes. Most women feel warmth or stinging; a topical anaesthetic is sometimes used on the vulva.
- Afterwards:there may be slight burning, discharge or small amounts of bleeding for a few days. It is recommended to avoid sex and tampons for about a week.
- Usual protocol:three sessions four to six weeks apart and, if there is benefit, maintenance sessions, generally annual.
Results: what to expect
- Genitourinary syndrome of menopause. Many uncontrolled studies report an improvement in symptoms. In randomised trials, laser treatment produced outcomes similar to vaginal oestrogen (Paraiso et al., 2020, Cruz et al., 2018), but in a sham-controlled trial it was no better than placebo after 12 months (Li et al., 2021). In other words, some of the improvement may be due to other factors.
- Duration of effect. When it exists, it seems to last months, which explains the recommendation for maintenance.
- Urine leakage and laxity. Modest, short-lived benefits in some studies; no difference compared with placebo in others.
Results vary from woman to woman and there is no way of predicting who will respond.
When it should not be done
- active vaginal or urinary infection;
- unexplained vaginal bleeding;
- pregnancy;
- untreated pre-malignant or malignant lesions of the cervix, vagina or vulva;
- advanced genital prolapse;
- recent pelvic radiotherapy;
- use of medicines that increase sensitivity to light, in some cases.
Risks and adverse effects
The most common adverse effects are mild and temporary: burning, discomfort, discharge, small amounts of bleeding, and urinary or vaginal infections. Less commonly reported adverse effects include burns, scarring, narrowing of the vagina, persistent pain and worsening pain during sex. These reports led the US Food and Drug Administration (FDA) to issue a warning in 2018 (FDA, 2018). The safety of repeated treatments over many years is not known.
When to see a doctor
Before any laser treatment, book a consultation to understand the cause of your complaints and find out about the alternatives. After a session, seek an assessment if you have severe pain, fever, foul-smelling discharge, heavy bleeding or burning that does not improve after a few days.
If in doubt, call the SNS 24 line (808 24 24 24). In an emergency, call 112.
At Luxmed Clinic
At Luxmed Clinic, any discussion about vaginal laser starts with a complete gynaecological assessment and an explanation of the options with the most evidence. If laser is a reasonable option in your case, we explain what the studies show, the number of sessions, the maintenance costs and the risks, so that you decide with all the information.
Talk to us
The assessment is a conversation, with no obligation. Tell us what concerns you and our team will reply.
This article is for information only and does not replace a medical assessment. Results vary from person to person.
Frequently asked questions
Does vaginal laser hurt?
Most women describe tolerable warmth or stinging. Treatment of the vulva can be more uncomfortable, and a topical anaesthetic may be used.
Can I have laser if I have had breast cancer?
It is one of the situations in which it is most discussed, but the evidence is limited. The decision should be made with the gynaecologist and the oncologist, after trying moisturisers and lubricants.
How long does the effect last?
When there is a benefit, it seems to last for months. That is why maintenance sessions are usually proposed.
Is it better than vaginal oestrogen?
There is no evidence that it is better. Low-dose vaginal oestrogen has been studied more extensively and is the first-line treatment for those who can use it.
Can I have sex afterwards?
It is recommended to wait about a week after each session.
Scientific references 7
- Li FG, Maheux-Lacroix S, Deans R, et al. Effect of fractional carbon dioxide laser vs sham treatment on symptom severity in women with postmenopausal vaginal symptoms: a randomized clinical trial. JAMA. 2021;326(14):1381-1389. Artigo
- Paraiso MFR, Ferrando CA, Sokol ER, et al. A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: the VeLVET trial. Menopause. 2020;27(1):50-56. Artigo
- Cruz VL, Steiner ML, Pompei LM, et al. Randomized, double-blind, placebo-controlled clinical trial for evaluating the efficacy of fractional CO2 laser compared with topical estriol in the treatment of vaginal atrophy in postmenopausal women. Menopause. 2018;25(1):21-28. Artigo
- Zerbinati N, Serati M, Origoni M, et al. Microscopic and ultrastructural modifications of postmenopausal atrophic vaginal mucosa after fractional carbon dioxide laser treatment. Lasers Med Sci. 2015;30(1):429-436. Artigo
- Preti M, Vieira-Baptista P, Digesu GA, et al. The clinical role of LASER for vulvar and vaginal treatments in gynecology and female urology: an ICS/ISSVD best practice consensus document. Neurourol Urodyn. 2019;38(3):1009-1023. Guideline
- U.S. Food and Drug Administration. FDA warns against use of energy-based devices to perform vaginal «rejuvenation» or vaginal cosmetic procedures: FDA Safety Communication. 30 de julho de 2018. (texto reproduzido pela Medsafe, Nova Zelândia) Site
- The North American Menopause Society. The 2020 genitourinary syndrome of menopause position statement. Menopause. 2020;27(9):976-992. Guideline
Keep exploring

